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Abstract
Background: WHO guidelines for the treatment of young children with suspected malaria have recently changed
from presumptive treatment to anti-malarial treatment guided by a blood slide or malaria rapid diagnostic test
(RDT). However, there is limited evidence of the safety of this policy in routine outpatient settings in Africa.
Methods: Children 3-59 months of age with a non-severe febrile illness and no obvious cause were enrolled over
a period of one year in a malaria endemic area of Tanzania. Treatment was determined by the results of a clinical
examination and RDT result, and blood culture and serum lactate were also collected. RDT-negative children were
followed up over 14 days.
Results: Over the course of one year, 965 children were enrolled; 158 (16.4%) were RDT-positive and treated with
artemether-lumefantrine and 807 (83.4%) were RDT-negative and treated with non-anti-malarial medicines.
Compared with RDT-positives, RDT-negative children were on average younger with a lower axillary temperature
and more likely to have a history of cough or difficulty in breathing. Six (0.6%) children became RDT-positive after
enrolment, all of whom were PCR-negative for Plasmodium falciparum DNA at enrolment. In addition, 12 (1.2%)
children were admitted to hospital, one with possible malaria, none of whom died. A bacterial pathogen was
identified in 9/965 (0.9%) children, eight of whom were RDT-negative and one was RDT-positive, but slide-negative.
Excluding three children with Salmonella typhi, all of the children with bacteraemia were ≤12 months of age.
Compared to double-read research slide results RDTs had a sensitivity of 97.8% (95%CI 96.9-98.7) and specificity of
96.3% (95%CI 96.3-98.4).
Conclusions: Use of RDTs to direct the use of anti-malarial drugs in young children did not result in any missed
diagnoses of malaria although new infections soon after a consultation with a negative RDT result may undermine
confidence in results. Invasive bacterial disease is uncommon in children with non-severe illness and most cases
occurred in infants with a current fever.
Background
The features of malaria overlap with those of other
common illnesses and, where diagnosis is based on clin-
ical history and examination alone, this often results in
a large degree of overtreatment for malaria [1]. For
many years this has been considered as a price worth
paying to ensure prompt treatment of malaria in young
children, but over the last decade a number of impor-
tant trends have driven a movement towards parasitolo-
gical testing to guide the use of anti-malarial drugs [2].
These include the replacement of older anti-malarial
drugs with the more expensive artemisinin combination
therapy (ACT), the need to minimize selection pressure
for drug-resistant strains of Plasmodium falciparum, the
need for more reliable surveillance data as malaria has
declined in many areas of Africa, and the relative
neglect of alternative diagnoses to malaria [3-7].
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In parallel to this, accurate and affordable rapid diag-
nostic tests for malaria (RDTs) have become available
over the last decade [8] and the 2010 WHO malaria
treatment guidelines now propose that wherever possi-
ble all patients suspected of malaria should be tested by
blood slide or RDT and only those with a positive test
result should receive anti-malarial treatment [9]. While
this should lead to a number of benefits, there is still
relatively little direct evidence that non-malarial treat-
ment in young febrile children in highly or moderately
endemic areas is safe, with a concern that a significant
number of malaria cases may be missed. The risks of
‘test negative malaria’ are consistently raised by clini-
cians cautious about this approach [10]. In addition clin-
icians need more evidence on the probabilities of
different non-malarial diagnoses, especially those that
require treatment with antimicrobial agents.
This study was conducted in a malaria endemic area
of Tanzania to document the clinical outcomes and
blood culture results of children with febrile illness
whose treatment had been guided by the results of a
commonly used RDT.
Methods
Study area
The study was conducted in the mother and child
health (MCH) clinic of Teule Hospital, the District
Designated Hospital of Muheza District, Tanzania. This
serves a predominantly rural population exposed to per-
ennial transmission of malaria with seasonal peaks coin-
ciding with the short and long rainy seasons. In
common with much of East Africa, malaria incidence
has declined in recent years; in1990 parasite prevalence
in children under the age of five years was approxi-
mately 80% and this had declined to 30% in 2008
[11,12]. In order to facilitate patient follow-up the study
area was defined as residence in one of the 85 villages
from which there had been > 10 paediatric admissions
to Teule Hospital in 2006.
Clinical and laboratory procedures
All children presenting to the MCH clinic were screened
for the following inclusion criteria; age 3-59 months and
resident within the study area, reported fever in the pre-
vious two days or current axillary temperature ≥37.5 C,
no obvious non-malarial cause of fever and no known
chronic illness. Children with evidence of severe illness
were admitted to the paediatric ward and excluded from
the study.
Following consenting procedures, a medical history
and clinical examination were undertaken according to
IMCI guidelines. Venous blood was drawn for culture
(2-5ml), haemoglobin concentration (Hemocue™,
Angelholm, Sweden), serum lactate (Lactate-Pro™,
Arkray Inc, Kyoto, Japan), HRP-2 based RDT for P. fal-
ciparum (Paracheck™, Orchid Biomedical, Mumbai,
India).
Giemsa-stained blood slides were prepared from
venous blood and independently double-read, with dis-
cordant results (either positive/negative discordance or
> 2-fold density difference above 400 parasites/μL)
resolved by an independent third reading. Microscopists
were blinded to RDT results. Parasite densities were cal-
culated from the geometric mean of the two closest
counts of asexual parasites/200 white blood cells assum-
ing 8,000 WBC/μl. Blood for culture was inoculated into
a BactALERT™ Paediatric-fan bottle (bioMérieux,
France) and incubated in the BacT/ALERT 3D auto-
mated microbial detection system. Cultures that flagged
positive were identified by standard methods. Cultures
positive for non-cryptococcal yeasts, coagulase-negative
Staphylococcus, Micrococcus, Corynebacterium, Bacillus
sp. or viridans group Streptococci were considered con-
taminants and classified as ‘negative culture’ unless a
pathogenic organism was also isolated. The laboratory
participated in a bacteriology external quality assurance
programme coordinated by a reference laboratory in
Moshi, Tanzania that participates successfully in exter-
nal quality assurance programmes of the College of
American Pathologists. At all visits, a malaria RDT,
blood slide and blood spot for parasite DNA identifica-
tion by polymerase chain reaction (PCR) were obtained
according to established methodology [13].
Children were treated according to IMCI guidelines
but anti-malarials or other medication with anti-malarial
activity was avoided in RDT-negative children. RDT-
negative children were seen and checked on Days 2, 7
and 14 following the initial visit (Day 0) with home vis-
its the following day (and up to 2 more days until seen)
if they did not attend. RDT-positive children were trea-
ted with artemether-lumefantrine (ALu) as recom-
mended in the Tanzanian Guidelines for Malaria
Diagnosis and Treatment (2006). RDT-positive children
were not routinely followed up but results of positive
blood cultures were promptly reviewed by a study clini-
cian and, if the isolate was judged to be a pathogen,
home visits were conducted for three consecutive days
or until the child was seen and appropriate treatment
and follow up was arranged. Children were also seen at
additional times on parental demand and admissions to
the hospital ward for children in the study were identi-
fied and clinical details obtained from hospital records.
Data management and analysis
Data were double-entered in MS Access and analysed in
Stata-11. Simple proportions and confidence intervals
were calculated for prevalence of pathogens, and risk of
malaria in RDT-negative cases at follow-up. Sensitivity
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and specificity of Paracheck against the gold standard of
double-read research miscroscopy was undertaken on
baseline samples. Groups were compared using Wil-
coxon rank-sum test for continuous variables and chi-
square test for proportions. The study was able to detect
prevalence of pathogens in 800 RDT-negative patients at
1% with 95%CI 0.5-2% and a 5% prevalence with a 95%
CI 3.6-6.6%.
Ethics
Written informed consent was obtained from the parent
or caretaker of each child, or witnessed verbal consent if
the parent could not read. The study was approved by
the Ethical Review Boards of the National Institute for
Medical Research in Tanzania (NIMR/HQ/R.8a/Vol.IX/
785) and the London School of Hygiene & Tropical
Medicine in the UK (LSHTM ethics # 5523).
Results
The study was conducted over one year from April
2009; 2592 children were screened, and 965 were eligi-
ble and enrolled (Figure 1). Of these, 158 were RDT-
positive and treated with ALu and 807 were RDT-
negative and received non-anti-malarial treatment. Base-
line characteristics by RDT result are shown in Table 1;
children who were RDT-negative were on average
younger with a lower axillary temperature and more
likely to have a history of cough or difficulty in breath-
ing (Table 1).
RDTs had a sensitivity of 98.6% (95%CI 97.8-99.3) and
specificity of 97.3% (95%CI 96.3-98.4) when compared
to double-read research slide results; 14.3% of blood
slides were positive with a negative predictive value of
RDT results of 99.8% (95%CI 99.4-100).
Of the 807 patients who were RDT-negative, 765
(94.8%) remained in the study for the 14 days of follow-
up at which time 461 (60.3%) of whom were reported
by the caretaker to be ‘completely well’. Of 42 patients
who exited before the end of the study, the parents of 6
children administered an anti-malarial drug during the
14-day follow-up period and all of these were RDT-
negative at their next research visit and a further six
children became RDT-positive after enrolment and were
treated with ALu, two of whom were slide-positive with
16,676 and 1,234 asexual parasites/μl respectively and all
of whom were PCR-negative for P. falciparum DNA at
DAY 14
763 RDT -neg
419/722 (58%) reported 
‘completely well’
965 children age 3-59 months 
with non-severe febrile illness 
enrolled. 
158 RDT -pos, all treated with 
ALu
DAY 7
2 new RDT-pos and slide pos, 
1234 and 16,676 para/mcl.
DAY 7
780 RDT Neg
DAY 0
807 RDT-neg.
DAY 2
801  RDT-neg
DAY 2
2 new RDT-pos, both  slide-
neg, treated and exit from 
study
2 new RDT-pos, one slide 
unreadable and one slide-
negative
8 admitted to hospital
5 took anantimalarial drug
6 lost to follow-up
4 admitted to hospital
1 took antimalarial drug
10 lost to follow-up
2,592 children screened. 
4  lost to follow-up
Figure 1 Children in the study by RDT result.
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enrolment. Twenty children were lost to follow-up of
whom 6 (30%) were untraceable and 14 (70%) had left
the study area but were reported (by telephone or
friends) to be well at the time they exited the study. In
addition, 12 children were admitted to hospital for
whom details are provided in Table 2.
Diagnoses made by the study clinician at the first con-
sultation are shown in Table 3. Almost half (383, 47.5%)
of RDT-negative and 29 (18.4%) of RDT-positive children
met WHO criteria for non-severe pneumonia and were
prescribed amoxicillin and an additional 34 (4.2%) of
RDT-negative and 19(12.0%) of RDT-positive children
also met these criteria but were not treated with amoxi-
cillin. There was no evidence of a trend of the proportion
of children with raised respiratory rate or a recent history
of ‘cough or difficulty in breathing’ with month of the
study that might indicate increased prescriber confidence
to withhold antibiotic treatment (p = 0.37 and p = 0.43
respectively). While 73% of respiratory rate values were
even, there was no apparent preference for values at or
above cut-off levels; the commonest values were 36/min
(9.7% of values) and 48/min (15.4% of values).
A bacterial pathogen was identified from blood culture
in 9/965 (0.9%) children in the study, 8 of whom were
RDT-negative and one was RDT-positive but slide-nega-
tive (Table 4). In addition, an organism judged to be a
contaminant was isolated in 56 (5.8%) of cultures. All of
the bacteraemic children were successfully treated as out-
patients and the majority (7/9) were treated with amoxi-
cillin at the first consultation before the blood culture
result was available. Clinical and laboratory features asso-
ciated with bacteraemia are shown in Table 5, none of
which reached 5% significance although ‘current fever’
(measured axillary temperature > = 37.5C) was positively
associated with bacteraemia (p = 0.08) and with sensitiv-
ity and specificity of 77.8% (95%CI 75.2-80.4) and 46.5%
(95%CI 43.4-49.6) respectively. In addition, with the
exception of children with S. typhi, all of the children
with bacteraemia were 12 months of age or younger
Discussion
While age, haemoglobin level and presence of respira-
tory symptoms provide some guide to diagnostic prob-
ability, clinical predictors of malaria are still insufficient
Table 1 Clinical and laboratory characteristics of RDT positive compared to RDT-negative children at enrolment into
the study
RDT-Positive, n = 158 RDT-Negative, n = 807 p*
Age in months, median(mean) 26 (28) 16 (20) < 0.001
Days ill, median(mean) 3 (3.8) 3 (3.3) 0.002
Haemoglobin g/dl, median(mean) 9.7 (9.6) 10.5 (10.4) < 0.001
Resp. rate/min, median (mean) 48 (46.3) 48 (47.4) 0.16
WHO criteria of pneumonia, n (%)† 48 (30.4%) 417 (51.6%) < 0.001
Diarrhoea or vomiting, n (%) 40 (25.3%) 155 (19.2%) 0.079
Axillary temperature, °C, median(mean) 38.1 (38.1) 37.4 (37.5) < 0.001
Blood lactate, mmol/L, median(mean) 2.2 (2.5) 1.8 (2.0) < 0.001
*Wilcoxon rank-sum test for continuous variables or chi-square test for proportions
† Cough or difficulty in breathing plus raised respiratory rate for age (> 40 breaths/min 12-59 months, > 50 breaths per minute 2-11 months of age)
Table 2 Diagnosis, treatment and outcome of 12 children admitted to hospital during the 14 days of follow-up.
Age (months) Diagnosis or clinical syndrome RDT result Blood slide result Treatment Outcome
24 m Acute diarrhoea Negative Negative Quinine and gentamycin Discharged well
7 m Acute diarrhoea Negative Negative IV rehydration Discharged well
22 m Acute diarrhoea Negative Negative IV rehydration Discharged well
8 m Suspected
pneumonia
Negative Negative Cotrimoxazole Discharged well
12 m* Clinical diagnosis of malaria Negative Not available Quinine Discharged well
8 m Acute diarrhoea Negative Not available IV rehydration Discharged well
7 m Febrile convulsion Not done Not available Paracetamol Discharged well
24 m* Fever and vomiting Not done Not available Quinine Discharged well
18 m* Fever and vomiting Not done Not available Quinine Discharged well
29 m Fever, convulsion, prostration Positive Not available Quinine Discharged well
18 m* Suspected dysentery Negative Negative IV rehydration Discharged well
18 m Pneumonia Not done Negative Amoxycillin Discharged well
*Admitted to non-study facility
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to guide treatment. The advent of RDTs provides the
potential to target anti-malarial treatment on a scale
that has hitherto been impossible. However, doubts
remain in the minds of many clinicians about the safety
of not treating parasite-negative patients for malaria,
and these have probably contributed to the observation
from a number of studies in Africa that up to half of
those with a negative rapid test or blood slide result for
malaria are treated with anti-malarials anyway. Addi-
tionally the question ‘if it is not malaria what is it?’ is
important for framing a rational diagnostic and treat-
ment strategy. Appropriate use of anti-microbial drugs
is a key issue given the high mortality of children
admitted to hospital with invasive bacterial disease but
whose treatment is restricted by high levels of resistance
to commonly used agents [14].
This study adds to other evidence that anti-malarial
treatment based on parasitological testing misses few
true cases of malaria. Njama-Meyer et al used expert
microscopy to guide the treatment of 2,359 illness epi-
sodes in children under the age of 10 years in a malaria-
endemic area of Uganda; fewer than 1% of initial blood
slide readings were false-negatives, and only 13 (0.8%) of
1,602 slide-negative illness episodes became positive
over the following even days, and none of these was
severely ill [15]. D’Acremont et al followed up 603
RDT-negative children who had not been treated for
malaria and only three children developed a positive
result in the following week, all of whom were success-
fully treated [16].
Although the study results are reassuring, the policy of
RDT-directed treatment for suspected malaria repre-
sents a substantial change in the delivery of routine care
in Africa and some questions still remain. Firstly, it is
impossible to distinguish between ‘new’ or ‘missed’ diag-
noses of malaria during routine follow-up of RDT-
Table 3 Diagnoses made by examining clinician at enrolment by RDT result
RDT-Negative RDT-Positive
First diagnosis Secondary diagnoses Total (%) First diagnosis Secondary diagnoses Total (%)
Upper resp. tract infection 150 5 155 (14.2) 4 6 10 (3.6)
Non-specific fever 182 6 188 (17.2) 0 0 0
Diarrhoea 72 40 112 (10.2) 2 7 9 (3.2)
Pneumonia 375 8 383 (35.0) 20 9 29 (10.6)
Malaria 0 0 127 31 158 (57.0)
Anaemia 0 206 206 (18.8) 0 59 59 (21.3)
Bronchitis/wheeze 0 3 3 (0.3) 0 0 0
Other 28 19 47 (4.4) 5 7 11 (4.1)
TOTAL 807 287 1,094 (100) 158 119 277 (100)
Table 4 Clinical and laboratory data on the 9 children whose blood grew a bacterial pathogen
Age
(mon)
Blood
slide/RDT
Organism Summary clinical and laboratory data *Antibiotic
susceptible
Antibiotic
resistant
8 Neg/Neg Acinitobacter Iwoffli 7 days cough, temp 36.8°, pulse 138/min, resp. rate 63/min,
lactate 1.4 mmol/L
amox, cip, ceft, gen,
nal
chlor, cip
8 Neg/Neg b-Haemolytic
streptococcus
3 days cough, temp 37.2°pulse 144/min, resp. rate 56/min,
lactate 1.1 mmol/L
eryth, ceft. Pen, amox.
7 Neg/Neg Gram-negative
coccus
3 days cough, temp 37.4°, pulse 167/min, resp. rate 64/min,
lactate 1.8 mmol/L
No data
8 Neg/Neg Haemphilus
influenzae
3 days cough and coryza, temp 37.7°, pulse 150/min, lactate
3.1 mmol/L
amox, ceft, gen chlor, cip, nal
10 Neg/Neg Non-Typhi
Salmonella
2 days cough, temp 39.5°, pulse 156, resp rate 64, lactate 2.0
mmol/L
amox, chlor, cip, ceft,
gen, nal
43 Neg/Neg Salmonella Typhi 2 days cough, temp 39.2, pulse 145/min, resp rate 39/min,
lactate 1.9 mmol/L
cip, ceft, gen chlor, cotrim,
amox
38 Neg/Neg Salmonella Typhi 4 days diarrhoea, temp 38.1°, pulse 120/min, resp rate 42/min,
lactate 3.3 mmol/L
chl, cip, cef, gen amox, cotrim.
47 Neg/Neg Salmonella Typhi 7 days febrile illness, temp 38.8, pulse 140/min, resp rate 36/
min, lacate 0.9 mmol/L
chl, cip, cef, nal cotrim, amox
12 Neg/Pos Staphylococcus
aureus
1 day cough, temp 37.4°, pulse 163/min, resp. rate 52/min,
lactate 0.9 mmol/L
chl, eryth, gen cotrim, amox
*Anti-microbial agents tested for in vitro susceptibility: amoxicillin (amox), chloramphenicol (chlor), cotrimoxazole (cotrim), ciprofloxacin (cip), erythromycin
(eryth), oxacillin(pen), ceftriaxone (ceft), nalidixic acid (nal).
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negative patients. As observed in the current study, a
significant minority of children will be admitted for
malaria within days of being seen with a non-severe feb-
rile illness and a negative RDT result. Although the PCR
primers used in this study were not the most sensitive,
the results suggest that the malaria diagnoses following
enrolment into the study were ‘new’ infections and that
it is rational and safe to treat RDT-negative children for
a non-malarial illness. However, the perception of clini-
cians and parents may be that a child with malaria has
been denied the best treatment as a result of application
of new guidelines with RDTs. Given evidence of a
strong preference for a diagnosis of malaria among par-
ents and clinicians [17], such an interpretation is quite
likely and may undermine efforts to implement the pol-
icy of RDT-directed anti-malarial treatment. To guard
against this, clinicians should be reminded that ‘no test
is perfect’ and to advise parents to bring their child back
if they remain unwell. Secondly, there is still a possibility
that presumptive treatment for malaria in all children
with fever might provide a benefit due to intermittent
prophylaxis that might protect against malaria and/or
anaemia. Recent results of trials of intermittent treat-
ment for malaria in children suggest that this is possible,
and a cluster randomized trial of presumptive compared
to RDT-directed anti-malarial treatment is in progress
[18].
The commonest indication for anti-microbial treat-
ment in our study was the IMCI diagnosis of non-severe
pneumonia. While the overlap between malaria and
pneumonia has been previously described both in severe
and non-severe illness, the proportion of children meet-
ing WHO criteria for non-severe pneumonia was higher
than expected from previous studies [15,19-21]. Prefer-
ential recording by study clinicians in order to justify
prescribing an anti-microbial drug seems unlikely as the
number of children meeting the WHO definition was
slightly higher than the number actually diagnosed. In
addition, there was no evidence of a change in the pro-
portion diagnosed with pneumonia as the study
progressed, nor was there evidence of clustering of
respiratory counts near the cut-off values that define
raised levels. It’s possible that ‘cough or difficulty
breathing’ was over-interpreted or there may be local
variations in the perception or reporting of respiratory
problems in children [22]. In addition, the finger-prick
undertaken approximately 15 minutes before examina-
tion may have resulted in transiently increased respira-
tory rates.
As new guidelines and RDTs are introduced across
Africa it is possible that there will be a compensatory
over-use of the IMCI diagnosis of non-severe pneumo-
nia but this will be difficult to assess since there is no
gold standard definition of the diagnosis of pneumonia.
Even of the true pneumonias some will be viral, includ-
ing the vaccine-preventable RSV pneumonias, where
antibiotics will make little positive impact on outcome
[23,24]. In addition, studies of the quality of care suggest
that IMCI procedures to diagnose pneumonia, in parti-
cular examining the chest and recording respiratory
rate, are not well undertaken outside research settings
[25,26].
Consistent with at least one other study, we found
that bacteraemia was uncommon in children with non-
severe illness, especially in children who were RDT-posi-
tive [27]. However, blood culture lacks sensitivity and
early recognition and treatment of blood stream infec-
tions has the potential to avert progression to severe
disease with high associated mortality [14,28]. While
RDTs can improve targeting of anti-malarial drugs there
is no comparable test for bacterial disease. The POC
measure of blood lactate was increased in children who
were RDT-positive compared to RDT-negative, but was
unhelpful in distinguishing between children with and
without invasive bacterial infection. While the small
numbers of children with bacteraemia in our study
reduced the likelihood of finding a statistically signifi-
cant association with clinical and laboratory features,
our findings are consistent with other studies that bac-
teraemia occurs predominantly in young children, up to
Table 5 Clinical and laboratory features of children by presence of a bacterial pathogen isolated from blood culture
Bacterial pathogen, n = 9 No bacterial pathogen, n = 956 p†
Median (mean) age in months 10 (20.0) 17 (21.0) 0.56
Days of illness, median (mean) 3 (3.6) 3 (3.4) 0.68
Cough or difficulty in breathing* (%) 7 (77.8%) 601 (62.8%) 0.35
Diarrhoea or vomiting* (%) 1 (11.1%) 194 (20.3%) 0.49
Median (mean) axillary temp,°C 38.1 (38.2) 37.5 (37.6) 0.08
Respiratory rate, median (mean)/min 52 (51.8) 48 (47.2) 0.15
Median (mean) blood lactate mmol/L 1.9 (2.1) 1.8 (2.0) 0.94
Median (mean) aemoglobin, g/dL 10.2 (10.4) 10.4 (10.3) 0.93
WHO criteria of non-severe pneumonia (%) 5 (55.6%) 460 (48.1%) 0.65
* Symptoms reported at any time in the previous 2 days
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three-quarters of whom present with a ‘current fever’.
However, these indicators lack both sensitivity and spe-
cificity and there is still a need for more accurate mea-
sures of bacterial infection; devices measuring acute
phase proteins such as C-reactive protein or procalcito-
nin merit further research [29].
This study has a number of inevitable limitations. The
study was conducted in hospital outpatients where the
patient population may differ in a number of ways from
those attending primary health facilities generally. The
accuracy of RDT interpretation may have been higher
than under routine practice, and certainly higher than
routine microscopy in some clinics in the region. Clini-
cians were aware that they were being observed (in the
sense that their findings and prescriptions were being
recorded) and may have been more likely to follow
IMCI guidelines and to prescribe antibiotics, thus over-
estimating antibiotic usage that would occur under simi-
lar conditions in routine practice. The clinical care pro-
vided in the study followed IMCI guidelines and did not
have access to an otoscope or urine examination result-
ing in possible neglect of otitis media or urinary tract
infections. The lack of validating investigations for the
IMCI diagnosis of pneumonia has already been
discussed.
In conclusion, this study demonstrates that use of
RDT’s to direct the use of anti-malarial drugs in young
children is a safe strategy and did not result in any
missed diagnoses of malaria. However, new episodes of
malaria do occur within a short period of an initial con-
sultation in malaria endemic areas and these may under-
mine confidence in parasitological testing for malaria.
Invasive bacterial disease is relatively uncommon in chil-
dren with non-severe illness; while most cases occurred
in infants with a current fever there is a need for more
specific diagnostic tests to detect these infections at the
point of care.
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